FDA panel hears from dissatisfied LASIK patients - Cameron Optometry | Cameron Optometry
FDA panel hears from dissatisfied LASIK patients

FDA panel hears from dissatisfied LASIK patients

Posted on 28th November 2011

The US Food and Drug Administration (FDA) has convened a special panel to hear from patients following concerns about patient satisfaction with LASIK.

The meeting discussed the experiences of patients who had suffered complications from the procedure. The FDA had received 140 complaints of side-effects and device malfunctions between 1998 and 2006 and said it was seeking advice over information currently available to patients considering or undergoing the procedure and whether changes should be made. The agency also confirmed it would conduct a study with the National Eye Institute and other bodies to assess the quality of life of patients after LASIK surgery


Related Posts

Cosmetic lenses created for our patients (and for Hollywood blockbusters)

19th February 2019

Heather Muir and Heather Grandon headed south to Hemel Hempstead to Cantor & Nissel, the company we use to manufacturer cosmetic lenses for our patients. We have used the company for many years, c...

Read more

Gillian Bruce awarded medal as part of masters

12th February 2019

In June last year, we shared the news that our clinical lead optometrist, Gillian Bruce, had passed her Masters of Science (MSc) degree in Primary Care Ophthalmology with distinction. As if that wasn...

Read more

Did you know these health conditions can be detected in a routine eye examination?

30th January 2019

Eyes are said to be the windows to the soul, but in fact they could be the windows to less ethereal parts of the body like the heart. An eye examination is recommended at least every two years to ...

Read more

Donald Cameron awarded OBE in New Year’s Honours List

29th December 2018

An Officer of the Order of the British Empire (OBE) medal has been awarded to Donald Cameron in the Queen’s New Year Honours List 2019. The award recognises the practice's former managing director's...

Read more